Stereotaxis to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
04 févr. 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
Stereotaxis Reports 2020 Third Quarter Financial Results
09 nov. 2020 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis to Report Third Quarter 2020 Financial Results on November 9, 2020
26 oct. 2020 16h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
First Hospitals in the World Adopt Genesis Robotic Technology for Cardiac Heart Rhythm Disorders
14 sept. 2020 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced it has...
Stereotaxis CEO Invited to Speak on Plenary Panel at RAPS Convergence 2020
08 sept. 2020 09h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
Stereotaxis to Present at Three Investor Conferences in September
28 août 2020 09h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
Journal of American College of Cardiology Publishes Pioneering Study Using Stereotaxis Robotic Technology to Treat Pulmonary Hypertension
26 août 2020 09h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a pioneering...
Stereotaxis Reports 2020 Second Quarter Financial Results
06 août 2020 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis and Acutus Medical Announce First Integrated Cardiac Ablation Procedure with TeleRobotic Support
31 juil. 2020 08h05 HE
|
Stereotaxis, Inc.
ST. LOUIS and CARLSBAD, Calif., July 31, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Acutus Medical today announced the first integrated cardiac ablation procedure benefiting from remote...
Stereotaxis to Report Second Quarter 2020 Financial Results on August 6, 2020
23 juil. 2020 16h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 23, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...